Irish medtech giant Medtronic has secured another US approval for its OmniaSecure defibrillation lead, expanding its use to ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded indication for the OmniaSecure™ defibrillation lead. Now ...
Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc ...
PRIMETIMER on MSN
Who is Daniel Robert and what happened to him? Health updates explored as Phillies pitcher rushed to hospital after sudden collapse
Daniel Robert’s health scare during Phillies spring training raises concern as the pitcher recovers after a cardiac event and ...
Global medical technology firm with diversified therapeutic portfolio Strong institutional backing reflects broad market ...
The battery problems behind a serious recall of Boston Scientific pacemakers have been ongoing for years, according to a New ...
Medtronic (NYSE: MDT) announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.
Congestive heart failure is a chronic heart condition that usually occurs in older people However people with a history of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results